Cargando…
P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429579/ http://dx.doi.org/10.1097/01.HS9.0000847788.96420.63 |
| _version_ | 1784779499638882304 |
|---|---|
| author | Wang, M. Mei, M. Barr, P. M. Barrientos, J. de Vos, S. Furman, R. Patel, K. Thompson, P. A. Choi, M. Kallam, A. Zhu, Y. Chakraborty, S. Marinello, P. Spurgeon, S. E. |
| author_facet | Wang, M. Mei, M. Barr, P. M. Barrientos, J. de Vos, S. Furman, R. Patel, K. Thompson, P. A. Choi, M. Kallam, A. Zhu, Y. Chakraborty, S. Marinello, P. Spurgeon, S. E. |
| author_sort | Wang, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429579 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94295792022-08-31 P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE Wang, M. Mei, M. Barr, P. M. Barrientos, J. de Vos, S. Furman, R. Patel, K. Thompson, P. A. Choi, M. Kallam, A. Zhu, Y. Chakraborty, S. Marinello, P. Spurgeon, S. E. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429579/ http://dx.doi.org/10.1097/01.HS9.0000847788.96420.63 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Wang, M. Mei, M. Barr, P. M. Barrientos, J. de Vos, S. Furman, R. Patel, K. Thompson, P. A. Choi, M. Kallam, A. Zhu, Y. Chakraborty, S. Marinello, P. Spurgeon, S. E. P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE |
| title | P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE |
| title_full | P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE |
| title_fullStr | P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE |
| title_full_unstemmed | P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE |
| title_short | P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE |
| title_sort | p1231: zilovertamab vedotin (mk-2140) for the treatment of non-hodgkin lymphoma: the phase 1 dose escalation and cohort expansion waveline-001 study of an anti-ror1 antibody-drug conjugate |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429579/ http://dx.doi.org/10.1097/01.HS9.0000847788.96420.63 |
| work_keys_str_mv | AT wangm p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT meim p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT barrpm p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT barrientosj p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT devoss p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT furmanr p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT patelk p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT thompsonpa p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT choim p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT kallama p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT zhuy p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT chakrabortys p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT marinellop p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate AT spurgeonse p1231zilovertamabvedotinmk2140forthetreatmentofnonhodgkinlymphomathephase1doseescalationandcohortexpansionwaveline001studyofanantiror1antibodydrugconjugate |